Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Blockade of growth factor inhibits diabetic nephropathy

Aug. 2, 2000

Vaniqa approved by FDA for women with unwanted facial hair

Aug. 2, 2000

Vitamin E therapy lowers inflammation and vascular disease risk in diabetic patients

Aug. 2, 2000

Research at AHP leads to identification of novel 5-HT2C agonists

Aug. 1, 2000

TPO mimetics identified as part of joint SB/Ligand program

Aug. 1, 2000

Hemosol seeks approval of Hemolink in Canada

Aug. 1, 2000

Antisense candidate for type 2 diabetes identified at Isis

July 31, 2000

Nonpeptide GLP-1 antagonists and their potential uses described in recent patent

July 28, 2000

New dosage form, indication approved for Bayer's cerivastatin

July 28, 2000

Pharmacia drops leridistim research program

July 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...